Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Teh Seng Pharmaceutical Mfg CoROCO:7860 -4.79%23 EBITDA Margin % is 25.26% as of Dec. 2025, which is 8% above its 10-year median of 23.29. GuruFocus rates ROCO:7860 with a GF Score™ of 23/100. The stock has 7 warning signs investors should review. Among 959 Drug Manufacturers companies, Teh Seng Pharmaceutical Mfg Co ranks better than 69.34% on this metric.
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Teh Seng Pharmaceutical Mfg Co EBITDA Margin % Related Terms
Teh Seng Pharmaceutical Mfg Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teh Seng Pharmaceutical Mfg Co EBITDA Margin % Chart
Teh Seng Pharmaceutical Mfg Co Annual Data
Trend
Dec23
Dec24
Dec25
EBITDA Margin %
23.29
29.15
20.78
Teh Seng Pharmaceutical Mfg Co Semi-Annual Data
Dec23
Jun24
Dec24
Jun25
Dec25
EBITDA Margin %
0.00
25.69
32.09
16.31
25.26
ROCO:7860 vs ZTS, UTHR: EBITDA Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Teh Seng Pharmaceutical Mfg Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teh Seng Pharmaceutical Mfg Co EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Teh Seng Pharmaceutical Mfg Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Teh Seng Pharmaceutical Mfg Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a EBITDA Margin % of 25.26% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. This is near median its historical median of 23.29. Over the past decade, Teh Seng Pharmaceutical Mfg Co's EBITDA Margin % has ranged from 20.78 to 29.15. According to the industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #294 out of 959 companies in the Drug Manufacturers industry, placing it in the top 30.7%.
Is Teh Seng Pharmaceutical Mfg Co's EBITDA Margin % too high?
Teh Seng Pharmaceutical Mfg Co's current EBITDA Margin % of 25.26% is near median its 10-year median of 23.29. Over the past 10 years, this metric has ranged from a low of 20.78 to a high of 29.15. The Drug Manufacturers industry median EBITDA Margin % is 12.54. Teh Seng Pharmaceutical Mfg Co's value of 25.26% is 101.4% above this industry median. Based on the distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #294 out of 959 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Teh Seng Pharmaceutical Mfg Co has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Teh Seng Pharmaceutical Mfg Co's EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #294 out of 959 companies for EBITDA Margin %. This puts Teh Seng Pharmaceutical Mfg Co in the upper half of its industry. The industry median EBITDA Margin % is 12.54. Teh Seng Pharmaceutical Mfg Co's value of 25.26% is 101.4% above this benchmark. Historically, Teh Seng Pharmaceutical Mfg Co's own EBITDA Margin % has ranged from 20.78 to 29.15 over the past decade. While the company's 10-year median is 23.29 vs. the industry median of 12.54, Teh Seng Pharmaceutical Mfg Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.54, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Teh Seng Pharmaceutical Mfg Co's current EBITDA Margin % of 25.26% is 101.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teh Seng Pharmaceutical Mfg Co's current EBITDA Margin % is 25.26%, which is near median its own 10-year median of 23.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teh Seng Pharmaceutical Mfg Co stock overvalued right now?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a current EBITDA Margin % of 25.26%. The current EBITDA Margin % is 25.26%, which is near median its 10-year median of 23.29 and 101.4% above the Drug Manufacturers industry median of 12.54. Teh Seng Pharmaceutical Mfg Co's overall GF Score™ is 23/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Teh Seng Pharmaceutical Mfg Co (ROCO:7860), the current EBITDA Margin % is 25.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Teh Seng Pharmaceutical Mfg Co Business Description
Teh Seng Pharmaceutical Mfg Co Ltd is engaged in the development and manufacturing of various pain relieving patches, cosmetic patches and biotechnology products. Its products include: Hydrogel Patches, Oil-Based Patches, Hot-Melt Patches, CMO & CRO for Transdermal Patch, Oral Film & Sublingual, Cosmetic Patches, Biotechnology Products and Daily Supplements.
23GF Score
Get the complete analysis for ROCO:7860
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:7860 has been successfully added to your 
